Are minority children the last to benefit from a new technology? Technology diffusion and inhaled corticosteriods for asthma

Medical Care

Volumn 44, Issue 1, 2006, Pages 81-86

  Ferris, Timothy G ^a   Kuhlthau, Karen ^a   Ausiello, John ^a   Perrin, James ^a   Kahn, Robert ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Asthma; Bronchodilators; Children; Disparities; Inhaled steroids; Quality of care; Race ethnicity; Technology diffusion

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; ASTHMA; CAUCASIAN; CHILD; CROSS-SECTIONAL STUDY; FEMALE; HISPANIC; HUMAN; INFANT; INFORMATION PROCESSING; INHALATIONAL DRUG ADMINISTRATION; MALE; MASS COMMUNICATION; METERED DOSE INHALER; MIDDLE AGED; MINORITY GROUP; NEWBORN; PRESCHOOL CHILD; UNITED STATES; UTILIZATION REVIEW;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AFRICAN AMERICANS; ASTHMA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DIFFUSION OF INNOVATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INFANT; INFANT, NEWBORN; MALE; METERED DOSE INHALERS; MIDDLE AGED; MINORITY GROUPS; UNITED STATES;

EID: 33644808422     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000188914.47033.cd     Document Type: Article

References (35)

1. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Washington, DC: National Academies Press; 2003.
2. Rogers EM. Diffusion of Innovation. 4th ed. New York, NY: The Free Press; 1995.
3. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992;47:1102-1114.
4. Coleman JS. Foundations for a theory of collective decisions. AJS Am J Sociol. 1966;71:615-627.
5. Coleman JS, Katz E, Menzel H. Social processes in physicians adoption of a new drug. J Chronic Diseases. 1959;9:1-19.
6. Maes S, Schlosser M. Changing health behaviour outcomes in asthmatic patients: a pilot intervention study. Soc Sci Med. 1988;26:359-364.
7. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997;277:887-891.
8. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991;325:388-392.
9. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest. 1995;108:28-35.
10. Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Disease. 1990;142:832-836.
11. Wennergren G, Kristjansson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in prevalence of asthma. J Allergy Clin Immunol. 1996;97:742-748.
12. Wise PH, Kotelchuck M, Wilson ML, et al. Racial and socioeconomic disparities in childhood mortality in Boston. N Engl J Med. 1985;313:360-366.
13. Bosco LA, Gerstman BB, Tomita DK. Variations in the use of medication for the treatment of childhood asthma in the Michigan Medicaid population, 1980 to 1986. Chest. 1993;104:1727-1732.
14. Finkelstein JA, Brown RW, Schneider LC, et al. Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics. 1995;95:389-394.
15. Joseph CL, Havstad SL, Ownby DR, et al. Racial differences in emergency department use persist despite allergist visits and prescriptions filled for antiinflammatory medications. J Allergy Clin Immunol. 1998; 101:484-490.
16. Lieu TA, Lozano P, Finkelstein JA, et al. Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics. 2002;109:857-865.
17. Ferris TG, Crain EF, Oken E, Wang L, et al. Insurance and quality of care for children with acute asthma. Ambulatory Pediatr. 2001;1:267-274.
18. Donahue JG, Fuhlbrigge AL, Finkelstein JA, et al. Asthma pharmacotherapy and utilization by children in 3 managed care organizations. The Pediatric Asthma Care Patient Outcomes Research Team. J Allergy Clin Immunol. 2000;106:1108-1114.
19. Lieu TA, Quesenberry CP, Charles P, et al. Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits. Pediatrics. 1997;100:334-341.
20. Bryant E, Shimizu I. Sample design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey. Vital & Health Stat. 1988;108:1-39.
21. Anonymous. The International Classification of Diseases, 9th Revision, Clinical Modification. Vol 1. 4 ed. New York: McGraw-Hill; 1995.
22. Steinman MA, Gonzales R, Linder JA, et al. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med. 2003;138:525-533.
23. Mansour ME, Lanphear BP, DeWitt TG. Barriers to asthma care in urban children: parent perspectives. Pediatrics. 2000;106:512-519.
24. Settipane RA, National Asthma E, Prevention P. Defining the effects of an inhaled corticosteroid and long-acting beta-agonist on therapeutic targets. Allergy Asthma Proc. 2003;24:85-89.
25. Gleason C. Statement Before the Institute of Medicine Committee on Clinical Research involving Children: Participation and Protection of Children in Clinical Reseach. Society for Pediatric Research-American Pediatric Society. Available at: http://www.aps-spr.org/Public_Policy/2003_Docs/IOM0709.htm. Accessed February 1, 2004.
26. Barbey JT, Lazzara R, Zipes DP. Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride. J Cardiovasc Pharmacol Ther. 2002;7:65-76.
27. Dalby-Payne JR, Morris AM, Craig JC. Meta-analysis of randomized controlled trials on the benefits and risks of using cisapride for the treatment of gastroesophageal reflux in children. J Gastroenterol Hepatol. 2003;18:196-202.
28. Majumdar SR, Inui TS, Gurwitz JH, et al. Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction. J Gen Intern Med. 2001;16:351-359.
29. Perrin JM, Kuhlthau KA, Gortmaker SL, et al. Generalist and subspecialist care for children with chronic conditions. Ambul Pediatr. 2002; 2:462-469.
30. Homer CJ, Szilagyi P, Rodewald L, et al. Does quality of care affect rates of hospitalization for childhood asthma? Pediatrics. 1996;98:18-23.
31. Homer CJ. Asthma disease management. N Engl J Med. 1997;337:1461-1463.
32. Ferris TG, Perrin JM, Manganello J, et al. Switching to Gatekeeping: changes in expenditures and utilization for children. Pediatrics. 2001; 108:283-290.
33. Scanlon DP, Chernew M, Lave JR. Consumer health plan choice: current knowledge and future directions. Annu Rev Public Health. 1997;18:507-528.
34. Kuttner R. Must good HMOs go bad? First of two parts: the commercialization of prepaid group health care. N Engl J Med. 1998;338:1558-1563.
35. Kuttner R. Must good HMOs go bad? Second of two parts. The search for checks and balances. N Engl J Med. 1998;338:1635-1639.